Loading...
Loading chart...





The current price of NVOS is 0 USD — it has increased 0 % in the last trading day.
Novo Integrated Sciences, Inc. is a parent company to its subsidiaries. The Company owns Canadian and United States subsidiaries that provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutic, diagnostic solutions, personalized product offerings, and rehabilitative science. The Company operates through two segments: Healthcare Services and Product Sales. Its specialized multidisciplinary primary healthcare services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, dietician and others. Its subsidiaries include Novo Healthnet Limited, Novomerica Health Group, Inc., PRO-DIP, LLC and others.
Wall Street analysts forecast NVOS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NVOS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Novo Integrated Sciences Inc revenue for the last quarter amounts to 3.00M USD, decreased -4.28 % YoY.
Novo Integrated Sciences Inc. EPS for the last quarter amounts to -0.74 USD, increased 640.00 % YoY.
Novo Integrated Sciences Inc (NVOS) has 127 emplpoyees as of January 30 2026.
Today NVOS has the market capitalization of 15.00M USD.